ConductScience.org, home

Trial · NCT05361499

A Controlled Human Pneumococcal Infection Model (PIM) Study

NCT05361499, Not applicable, Completed, Radboud University Medical Center

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Controlled Human Pneumococcal Infection Model (PIM) Study. Trials, record NCT05361499. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05361499

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Controlled Human Pneumococcal Infection Model (PIM) Study
NCT number
NCT05361499
Status
Completed
Phases
Not applicable
Enrollment
20 participants, actual
Lead sponsor
Radboud University Medical Center
Conditions
Streptococcus Pneumoniae Infection
Interventions
Sp_6B, Amoxicillin 500 mg
First posted
2022-05-04
Last updated
2023-02-22

Source ClinicalTrials.gov

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPercentage of volunteers infected with S. pneumoniae serotype 6B following inoculation.up to 4 weeks after inoculation
SecondaryThe number of participants with sollicited AEs that are related to infectionfrom the baseline visit (between day -1 and -6) till the end of the study (day 28 ± 3)
SecondaryThe number, type and severity of sollicited AEs that are related to infectionfrom the baseline visit (between day -1 and -6) till the end of the study (day 28 ± 3)
SecondaryNumber of sampling timepoints with S. pneumoniae culture-positive nasal wash samples post-inoculationOn day 3, 7, 14 and 28 after inoculation
SecondaryNumber of colony forming units (CFUs) per ml detected in nasal wash of infected participants at each sampling timepointOn day 3, 7, 14 and 28 after inoculation
SecondaryConcentrations of S. pneumoniae-specific antibodies in blood and mucosal samples at the various sampling time pointsOn day 3, 7, 14 and 28 after inoculation
OtherBacterial load as determined by PCR of pneumococcal genes at each sampling time pointOn day 3, 7, 14 and 28 after inoculation
OtherCellular responses in blood and mucosal samples at various timepointsOn day 3, 7, 14 and 28 after inoculation
OtherSoluble mediators in mucosal or blood samples at various timepointsOn day 3, 7, 14 and 28 after inoculation
OtherExpression level of host genes at various timepointsOn day 3, 7, 14 and 28 after inoculation

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05361499

GET https://conductscience.org/api/trials/v1/NCT05361499/registered